World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
48284
World Ranking
15346
National Ranking
7738

Overview

Lucian R. Chirieac is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on the fields of Medicine, with a concentration in Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, and Cancer Research.

The scientist's work addresses several specialized topics, including:

  • Occupational and environmental lung diseases
  • Pleural and pulmonary diseases
  • Lung cancer treatments and mutations
  • Lung cancer diagnosis and treatment
  • Pancreatic and hepatic oncology research
  • Medical imaging and pathology studies
  • Cancer genomics and diagnostics

Lucian R. Chirieac has contributed to numerous publications, prominently featuring in several journals:

  • Journal of the National Comprehensive Cancer Network (7 publications)
  • Archives of Pathology & Laboratory Medicine (4 publications)
  • Modern Pathology (3 publications)
  • UNC Libraries (3 publications)
  • Journal of Thoracic Oncology (2 publications)

Some recent papers featuring Chirieac's work include:

  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021, 2021, Journal of the National Comprehensive Cancer Network
  • Non-Small Cell Lung Cancer, Version 4.2024, 2024, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023, 2023, Journal of the National Comprehensive Cancer Network
  • Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center, 2020, Journal of Thoracic Oncology

Chirieac frequently collaborates with several researchers, including:

  • Yin P. Hung
  • Douglas E. Wood
  • Dara L. Aisner
  • Jessica R. Bauman
  • Ankit Bharat

Best Publications

  • The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

    William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe

  • Somatic mutations affect key pathways in lung adenocarcinoma

    Li Ding;Gad Getz;David A. Wheeler;Elaine R. Mardis

  • Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Alice T. Shaw;Beow Y. Yeap;Mari Mino-Kenudson;Subba R. Digumarthy

  • BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

    D Li;L Ambrogio;L Ambrogio;T Shimamura;S Kubo

  • Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

    Jeffrey A. Engelman;Jeffrey A. Engelman;Liang Chen;Xiaohong Tan;Katherine Crosby

  • Characterizing the cancer genome in lung adenocarcinoma

    Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner

  • LKB1 modulates lung cancer differentiation and metastasis

    Hongbin Ji;Matthew R. Ramsey;D. Neil Hayes;Cheng Fan

  • Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

    Wenjun Zhou;Dalia Ercan;Liang Chen;Cai-Hong Yun

  • Non–Small Cell Lung Cancer

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Andrew Chang

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

    Adam J. Bass;Adam J. Bass;Hideo Watanabe;Hideo Watanabe;Craig H. Mermel;Craig H. Mermel;Soyoung Yu

  • Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

    Raphael Bueno;Eric W Stawiski;Leonard D Goldstein;Steffen Durinck

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • The biology and treatment of EML4-ALK non-small cell lung cancer.

    Takaaki Sasaki;Scott J. Rodig;Lucian R. Chirieac;Pasi A. Jänne;Pasi A. Jänne

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • Guidelines for pathologic diagnosis of Malignant Mesothelioma: 2017 Update of the consensus statement from the International Mesothelioma Interest Group

    Aliya Noor Husain;Thomas V. Colby;Nelson G. Ordóñez;Timothy Craig Allen

  • A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

    Mari Mino-Kenudson;Lucian R. Chirieac;Kenny Law;Jason L. Hornick

  • Non-small cell lung cancer: Clinical practice guidelines in oncology

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Matthew G. Blum

Frequent Co-Authors

Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
William G. Richards
William G. Richards Brigham and Women's Hospital
Kwok-Kin Wong
Kwok-Kin Wong New York University
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
Geoffrey I. Shapiro
Geoffrey I. Shapiro Harvard University
Beow Y. Yeap
Beow Y. Yeap Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Pasi A. Jänne
Pasi A. Jänne Harvard University
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're planning to study Medicine in the USA, you may want to explore flexible online programs that support diverse career goals in healthcare. Many students seek affordable and accelerated options, whether they're aiming for advanced clinical roles or health administration positions.

For current nurses looking to advance quickly, there are easiest dnp programs designed for working professionals. Those interested in entering the field fast may prefer a 6 month lpn program online to start gaining practical experience sooner.

Registered nurses who wish to specialize as nurse practitioners can consider bsn to np programs online, some of which offer focused tracks like psychiatric-mental health. For those interested in the business side of healthcare, pursuing a health care administration degree online can open opportunities in management and organizational leadership.

Choosing an online degree allows more flexibility and can fit around clinical or family commitments. These pathways support a wide range of professional aspirations within the ever-growing healthcare industry.

Best Scientists Citing Lucian R. Chirieac

Trending Scientists

Recently Published Articles